Blockbuster drug
Bayer and Regeneron secure PI against Formycon concerning Eylea
For now, Formycon cannot launch its biosimilar of the macular degeneration treatment Eylea in various European markets. Munich Regional Court yesterda
...
26 September 2025 by Konstanze Richter